{"ticker": {"uuid": "2b8ccb47-20d8-453a-aaeb-420baad528ef", "symbol": "688331", "name": "RemeGen Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Price to book forward of RemeGen Co. Ltd. Class A \u2013 SSE:688331", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQZmdHaTRrWkl3a0JSSmJSOGZRSHQyZk9xLThHZ0k1QjloS0ZEYnR4VUY4d1pPYTVQeC1iQjdrQzdsd2ZmVTdZVXg2UU1SaC1WWGVZeUl6Ym9xWVpfbmdxdE1HWUZubnhON0JEN01wZmNUU3FxMllLcFpETVBZT3Z0eDVhXzJCMW1XOThFR25TRFRHNlZZSDlCQzA3NA?oc=5", "source_name": "TradingView", "published_at": "2026-06-28T11:37:34+00:00", "published_display": "28 Jun 2026 11:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RemeGen scores out-licensing triple play with AbbVie deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPYzRSb1NuaXBnbTF2N0pENEVLSmFmWGZHY1NITW1KX0lyOUZob1JSV21XemZkUVNoOHdnaEsyaVNiWUxBMmdaRVVaRDlRaUdIeXFYUkd4bVY1OUJqRnN1MjBYZERzY183R1lDWnRHaC1ERUs3YUxWNGNQTUhrWHNobWpxTkZ3dmVQOTVBR0h3?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxNd1gxZ0tUU0dxMkN2bjRNQVptQXBJODBXTEpsRklRMFc5TkVCN0lOUGM3SUh3eEFTakUwZGRJbW1vM2V2aEFoMGFXZFc1b181MWJoY054ckx3WGR6RzhnakhPTkVxeUF1bkZfXzd3YW53NFI5T0xyS2xlcFBvT1FJNXN4UVY4NXVLU1dnRHdGVFNocnVYaW92RkQtVmZjZWxra20yLXl3MFFFZnpWbG5LeDI0TWxNSWQyUjZUTUxqN0FOSER2bF9tQl81b19McE5nSGQ4VzRvc0pNbmttekxGVThZVjhSaEEwMHkyeHliRVZhU19IYXF1clFRdFZja2VfS0FwbHNqUWoycUU4YXBsZjVONmxhRlhhVVE?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REMEGEN CO., LTD. - H SHARES (9995) - stock price, quote, history", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQZEpmMGE3SFh3THpNS0p2ZGlUM0tQcjV5MTdwZW5Sc1VVMVEtVGFjbHROc0RTZmh6YWpFc2Q5VDVzWFJtZ2JSLTdYdzk5MFFOc0tKM2VlV25fR1lwaEhXNGhXb1RVTEJEdVFHWWNqNWgwS2hqR1BsVHJvTUxWVU5IclNsbGt6LTN6QWhQTEd0SQ?oc=5", "source_name": "hkex.com.hk", "published_at": "2020-11-09T08:00:00+00:00", "published_display": "09 Nov 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to book forward of RemeGen Co. Ltd. Class A \u2013 SSE:688331", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQZmdHaTRrWkl3a0JSSmJSOGZRSHQyZk9xLThHZ0k1QjloS0ZEYnR4VUY4d1pPYTVQeC1iQjdrQzdsd2ZmVTdZVXg2UU1SaC1WWGVZeUl6Ym9xWVpfbmdxdE1HWUZubnhON0JEN01wZmNUU3FxMllLcFpETVBZT3Z0eDVhXzJCMW1XOThFR25TRFRHNlZZSDlCQzA3NA?oc=5", "source_name": "TradingView", "published_at": "2026-06-28T11:37:34+00:00", "published_display": "28 Jun 2026 11:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RemeGen scores out-licensing triple play with AbbVie deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPYzRSb1NuaXBnbTF2N0pENEVLSmFmWGZHY1NITW1KX0lyOUZob1JSV21XemZkUVNoOHdnaEsyaVNiWUxBMmdaRVVaRDlRaUdIeXFYUkd4bVY1OUJqRnN1MjBYZERzY183R1lDWnRHaC1ERUs3YUxWNGNQTUhrWHNobWpxTkZ3dmVQOTVBR0h3?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxNd1gxZ0tUU0dxMkN2bjRNQVptQXBJODBXTEpsRklRMFc5TkVCN0lOUGM3SUh3eEFTakUwZGRJbW1vM2V2aEFoMGFXZFc1b181MWJoY054ckx3WGR6RzhnakhPTkVxeUF1bkZfXzd3YW53NFI5T0xyS2xlcFBvT1FJNXN4UVY4NXVLU1dnRHdGVFNocnVYaW92RkQtVmZjZWxra20yLXl3MFFFZnpWbG5LeDI0TWxNSWQyUjZUTUxqN0FOSER2bF9tQl81b19McE5nSGQ4VzRvc0pNbmttekxGVThZVjhSaEEwMHkyeHliRVZhU19IYXF1clFRdFZja2VfS0FwbHNqUWoycUU4YXBsZjVONmxhRlhhVVE?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REMEGEN CO., LTD. - H SHARES (9995) - stock price, quote, history", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQZEpmMGE3SFh3THpNS0p2ZGlUM0tQcjV5MTdwZW5Sc1VVMVEtVGFjbHROc0RTZmh6YWpFc2Q5VDVzWFJtZ2JSLTdYdzk5MFFOc0tKM2VlV25fR1lwaEhXNGhXb1RVTEJEdVFHWWNqNWgwS2hqR1BsVHJvTUxWVU5IclNsbGt6LTN6QWhQTEd0SQ?oc=5", "source_name": "hkex.com.hk", "published_at": "2020-11-09T08:00:00+00:00", "published_display": "09 Nov 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 71, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 116.01, "latest_week": "2026-07-17", "one_week_move": -13.4, "four_week_move": 1.3, "twelve_week_move": -12.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.136033, "market_dynamics_buy_signal": false, "relative_strength": 18.060757, "fair_value_gap": 76.9, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 49.4253, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-13.4% over one week, +1.3% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 1}, {"label": "thebambooworks.com", "count": 1}, {"label": "PR Newswire", "count": 1}, {"label": "hkex.com.hk", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "71/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-13.4% over one week, +1.3% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to book forward of RemeGen Co. Ltd. Class A \u2013 SSE:688331"}], "updated_at": "2026-07-23T03:34:39.329979+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}